C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2004
11/04/2004	US20040220229 insulin resistance; central nervous system disorders; vision defects; anticholesterol agents;antilipemic agents; antiischemic agents
11/04/2004	US20040220223 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
11/04/2004	US20040220215 antidiabetic agents; insulin resistance; adjust glucose tolerance; anticholesterol agents; cardiovascular disorders; obesity; antiinflammatory agents
11/04/2004	US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004	US20040220201 Tyrosine kinase inhibitors
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220191 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
11/04/2004	US20040220188 Alkylidene pyrazolidinedione derivatives
11/04/2004	US20040220183 inhibiting tumor necrosis factor; respiratory system disorders; prevent neutrophil infiltration in lungs; skin disorders
11/04/2004	US20040220182 tyrosine kinase inhibitor; antitumor agents
11/04/2004	US20040220177 Anticancer agents
11/04/2004	US20040220174 for example, 1-(4-methoxyphenyl)-7-oxo-6-[5-(2-oxo-1-piperidinyl)2-pyridinyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; use as anticoagulant agent for treatment of thromboembolic disorders
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004	CA2526897A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004	CA2522682A1 Indazole derivatives as jnk inhibitors
11/04/2004	CA2522631A1 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
11/04/2004	CA2522476A1 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
11/03/2004	EP1473293A1 Chromenon derivatives
11/03/2004	EP1472247A1 Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004	EP1472225A2 2-piperazine-pyridines useful for treating pain
11/03/2004	EP1472223A1 Gamma secretase inhibitors
11/03/2004	EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471786A1 Microbiocidal n-phenyl-n- 4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives
11/03/2004	EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004	EP1228087A4 Antibody catalysis of enantio- and diastereo-selective aldol reactions
11/03/2004	EP0942906B1 Compounds useful for inhibition of farnesyl protein transferase
11/03/2004	CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group
11/03/2004	CN1543455A 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
11/03/2004	CN1543346A Novel compounds
11/03/2004	CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004	CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004	CN1173980C Organometallic complex molecule and organic electroluminescent device using the same
11/03/2004	CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/03/2004	CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
11/02/2004	US6812238 Water soluble fungicides for systemic mycoses; oral and parenteral administration
11/02/2004	US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004	US6812231 Inhibiting activated blood-coagulation factor x
11/02/2004	US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004	US6812225 Pyschological disorders; antidepressants
11/02/2004	CA2315614C Pyrazoles
11/02/2004	CA2282279C Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
10/2004
10/28/2004	WO2004092168A1 Cgrp receptor antagonists
10/28/2004	WO2004092166A2 Cgrp receptor antagonists
10/28/2004	WO2004092164A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004	WO2004092162A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/28/2004	WO2004092154A1 Compositions useful as inhibitors of protein kinases
10/28/2004	WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004	WO2004092140A1 Biaryl substituted pyrazoles as sodium channel blockers
10/28/2004	WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	WO2004092132A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	WO2004092131A1 Indole derivatives as ppar modulators
10/28/2004	WO2004092130A2 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
10/28/2004	WO2004092124A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004091604A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	WO2004091518A2 Cxcr4 chemokine receptor binding compounds
10/28/2004	WO2004091485A2 Aminoquinoline compounds
10/28/2004	WO2004080422A3 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
10/28/2004	WO2004078732B1 N-aryl heteroaromatic products, compositions containing same and use thereof
10/28/2004	WO2004038374A3 Alkyne derivatives as tracers for metabotropic glutamate receptor binding
10/28/2004	WO2004037789A3 Methylene urea derivatives as raf-kinase inhibitors
10/28/2004	US20040215014 Auroyl cyclic amines for controlling behavior or appetite
10/28/2004	US20040214999 Novel compounds for chemiluminescense procedures
10/28/2004	US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same
10/28/2004	US20040214871 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester
10/28/2004	US20040214868 Treatment or prevention of type 2 diabetes; chemical synthesis; 2-[ benzoyl]aminopyridine-5-carboxylate derivatives
10/28/2004	US20040214866 Antidiabetic agents; dietetics; hypoglycermic agents; stable, high melting crystalline material, suitable for bulk preparation and handling
10/28/2004	US20040214865 Suitable for bulk preparation and handling; treating diabetes mellitus
10/28/2004	US20040214841 Quinazoline derivatives for treatment of tumours
10/28/2004	US20040214832 Piperazine derivative renin inhibitors
10/28/2004	US20040214828 the agronomic pesticide is combined with surfactants and solid or liquid diluents, and optionally combined with another active ingredient; nontoxic
10/28/2004	US20040214818 Alzheimer's disease; Parkinson's disease; Huntington's disease; cognition activators; learning enhancement; central nervous system disorders
10/28/2004	US20040214817 Diaminotriazoles useful as inhibitors of protein kinases
10/28/2004	US20040214816 Substituted imidazoles useful in the treatment of inflammatory diseases
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214812 4-Substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as beta-lactamase inhibitors
10/28/2004	US20040214107 optical and electro-optical apparatus comprising recording layer consists of organic pigments and stabilizer agents, and reflection layers formed on light transmitting substrates; sensitivity for red light
10/28/2004	US20040213947 Optical information-recording medium and dye
10/28/2004	US20040213736 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and\or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination
10/28/2004	CA2522595A1 Compositions useful as inhibitors of protein kinases
10/28/2004	CA2522195A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	CA2522118A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521915A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004	CA2521678A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/28/2004	CA2521619A1 Aminoquinoline compounds
10/28/2004	CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004	CA2521135A1 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
10/28/2004	CA2520804A1 Biaryl substituted pyrazoles as sodium channel blockers
10/28/2004	CA2520259A1 Cxcr4 chemokine receptor binding compounds
10/27/2004	EP1471055A1 6-phenylpyridyl-2-amine derivatives
10/27/2004	EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004	EP1470752A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives
10/27/2004	EP1470131A2 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them

1 ... 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 ... 628